These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22387938)

  • 1. Real-time UV imaging of piroxicam diffusion and distribution from oil solutions into gels mimicking the subcutaneous matrix.
    Ye F; Larsen SW; Yaghmur A; Jensen H; Larsen C; Østergaard J
    Eur J Pharm Sci; 2012 May; 46(1-2):72-8. PubMed ID: 22387938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release into hydrogel-based subcutaneous surrogates studied by UV imaging.
    Ye F; Larsen SW; Yaghmur A; Jensen H; Larsen C; Ostergaard J
    J Pharm Biomed Anal; 2012 Dec; 71():27-34. PubMed ID: 22889608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time UV imaging of drug diffusion and release from Pluronic F127 hydrogels.
    Ye F; Yaghmur A; Jensen H; Larsen SW; Larsen C; Østergaard J
    Eur J Pharm Sci; 2011 Jul; 43(4):236-43. PubMed ID: 21550399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
    Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulations.
    Rafiee-Tehrani M; Mehramizi A
    Drug Dev Ind Pharm; 2000 Apr; 26(4):409-14. PubMed ID: 10769782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effects of fatty acids on piroxicam permeation through rat skins.
    Shin SC; Shin EY; Cho CW
    Drug Dev Ind Pharm; 2000 May; 26(5):563-6. PubMed ID: 10789070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion.
    Curdy C; Kalia YN; Naik A; Guy RH
    J Control Release; 2001 Sep; 76(1-2):73-9. PubMed ID: 11532314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piroxicam bioadhesive ocular inserts: physicochemical characterization and evaluation in prostaglandin-induced inflammation.
    Gilhotra RM; Gilhotra N; Mishra DN
    Curr Eye Res; 2009 Dec; 34(12):1065-73. PubMed ID: 19958126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin diffusion and self-association characterized by real-time UV imaging and Taylor dispersion analysis.
    Jensen SS; Jensen H; Cornett C; Møller EH; Østergaard J
    J Pharm Biomed Anal; 2014 Apr; 92():203-10. PubMed ID: 24530973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats.
    Shin S; Cho C; Oh I
    Int J Pharm; 2000 Jan; 193(2):213-8. PubMed ID: 10606784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels.
    Attia MA; El-Gibaly I; Shaltout SE; Fetih GN
    Int J Pharm; 2004 May; 276(1-2):11-28. PubMed ID: 15113610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release from oil injectables for intra-articular administration: Importance of interfacial area, diffusivity and partitioning.
    Thing M; Larsen C; Østergaard J; Jensen H; Larsen SW
    Eur J Pharm Sci; 2012 Feb; 45(3):351-7. PubMed ID: 22178293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
    Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases.
    A-sasutjarit R; Sirivat A; Vayumhasuwan P
    Pharm Res; 2005 Dec; 22(12):2134-40. PubMed ID: 16215775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation of piroxicam from the poloxamer gels.
    Shin SC; Cho CW; Choi HK
    Drug Dev Ind Pharm; 1999 Mar; 25(3):273-8. PubMed ID: 10071819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release studies of insulin from lipid implants in solution and in a hydrogel matrix mimicking the subcutis.
    Jensen SS; Jensen H; Møller EH; Cornett C; Siepmann F; Siepmann J; Østergaard J
    Eur J Pharm Sci; 2016 Jan; 81():103-12. PubMed ID: 26478185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringeable Pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin.
    Simões SM; Veiga F; Torres-Labandeira JJ; Ribeiro AC; Sandez-Macho MI; Concheiro A; Alvarez-Lorenzo C
    Eur J Pharm Biopharm; 2012 Jan; 80(1):103-12. PubMed ID: 22005155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the surfactant on the availability of piroxicam as a poorly hydrosoluble drug from suppositories.
    Dal Zorro M; Franceschinis E; Punchina A; Realdon N
    Pharmazie; 2012 Jan; 67(1):37-45. PubMed ID: 22393829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDS-aided immobilization and controlled release of camptothecin from agarose hydrogel.
    Liu J; Li L
    Eur J Pharm Sci; 2005 Jun; 25(2-3):237-44. PubMed ID: 15911219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA
    J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.